Innoviva Inc (INVA) stock news · P/E 4.8, rev $411.3M
Innoviva Inc (INVA) is a biotechnology company listed on US.
This INVA news page leads with what Innoviva Inc filed — not a scraped headline mill.
No cached 8-K sentence for INVA yet. We will not pad this page with generic market recap.
Latest reported INVA revenue for 2025-12-31 was $411.3M. Net income was $271.2M. Revenue was up 14.7% from 2024-12-31 to 2025-12-31. INVA currently screens at market cap $1.66B and trailing P/E 4.8.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the INVA stock page; for the tape open the quote page.
INVA stock news FAQ
What are INVA's latest revenue and net income?
Latest cached Innoviva Inc (INVA) revenue for Dec 31, 2025 was $411.3M. Net income was $271.2M. Statements: https://lician.com/financials/inva
How did INVA revenue change from the prior cached period?
Cached Innoviva Inc (INVA) revenue was up 14.7% from $358.7M (Dec 31, 2024) to $411.3M (Dec 31, 2025). Statements: https://lician.com/financials/inva
What is INVA's P/E ratio?
Innoviva Inc (INVA) trailing P/E is 4.82 on the latest cached fundamentals snapshot.
What is INVA's market cap?
Innoviva Inc (INVA) market cap is $1.66B on the latest cached fundamentals snapshot.
What kind of company is INVA?
Innoviva Inc (INVA) is a biotechnology company listed on US.
Where is INVA stock news listed?
Cached stock news for Innoviva Inc (INVA) is listed at https://lician.com/news/inva. Filings: https://lician.com/sec/inva
Not investment advice.